Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
A double blind, Placebo (Vehicle) and Standard Care controlled, randomised study to
investigate the clinical safety and toleration (including systemic pharmacokinetics), wound
healing and antiscarring potential of two applications of intradermal RN1001 in healthy male
subjects